二巯基苯并咪唑衍生物贝米替(bemityl)是苏联新研制的一种免疫刺激剂,能增强RNA和蛋白的适应性合成,提高细胞和整个机体生物能量过程的活性,有助于在远航等不良条件下加快适应和提高其耐力。远航海员的免疫抗力发生变化,易患各种疾病,作者为此用贝米替研究预防机体防御功能发生的脱适应障碍,以求保持工作能力和降低发病率。 The dimercaptobenzimidazole derivative, bemityl, is a newly developed immunostimulant in the Soviet Union that enhances the adaptive synthesis of RNA and proteins and enhances the bioenergetic process of cells and the body as a whole, And other adverse conditions to speed up adaptation and improve their endurance. Voyager seafarers immune changes occur, susceptible to various diseases, the authors use this for the study of Bemis to prevent the body’s defensive dysfunction disorder, in order to maintain the ability to work and reduce the incidence.